193 related articles for article (PubMed ID: 25017444)
1. Perspectives on clinical trial data transparency and disclosure.
Alemayehu D; Anziano RJ; Levenstein M
Contemp Clin Trials; 2014 Sep; 39(1):28-33. PubMed ID: 25017444
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials transparency and the Trial and Experimental Studies Transparency (TEST) act.
Logvinov I
Contemp Clin Trials; 2014 Mar; 37(2):219-24. PubMed ID: 24440100
[TBL] [Abstract][Full Text] [Related]
3. Promoting transparency in pharmaceutical industry-sponsored research.
Ross JS; Gross CP; Krumholz HM
Am J Public Health; 2012 Jan; 102(1):72-80. PubMed ID: 22095335
[TBL] [Abstract][Full Text] [Related]
4. Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.
Miller JE; Wilenzick M; Ritcey N; Ross JS; Mello MM
BMJ Open; 2017 Dec; 7(12):e017917. PubMed ID: 29208616
[TBL] [Abstract][Full Text] [Related]
5. Access to data from clinical trials sponsored by pharmaceutical companies.
West R
Addiction; 2007 May; 102(5):682-3. PubMed ID: 17493100
[No Abstract] [Full Text] [Related]
6. Protecting patient privacy when sharing patient-level data from clinical trials.
Tucker K; Branson J; Dilleen M; Hollis S; Loughlin P; Nixon MJ; Williams Z
BMC Med Res Methodol; 2016 Jul; 16 Suppl 1(Suppl 1):77. PubMed ID: 27410040
[TBL] [Abstract][Full Text] [Related]
7. Regulatory transparency: social, technical, and ethical aspects of clinical trial data access.
Sousa VD; Silveira D
Rev Panam Salud Publica; 2015 Jun; 37(6):430-4. PubMed ID: 26245179
[TBL] [Abstract][Full Text] [Related]
8. Out in the open.
Nat Biotechnol; 2005 Feb; 23(2):153. PubMed ID: 15696130
[No Abstract] [Full Text] [Related]
9. Drug companies and publishers set out 10 steps to enhance credibility of industry sponsored trials.
Roehr B
BMJ; 2012 May; 344():e3767. PubMed ID: 22641830
[No Abstract] [Full Text] [Related]
10. Pharmaceutical research: paradox, challenge or dilemma?
Sheikh AL
East Mediterr Health J; 2006; 12 Suppl 1():S42-9. PubMed ID: 17037688
[TBL] [Abstract][Full Text] [Related]
11. Researchers raise concerns about secrecy in company-sponsored clinical trials.
Mangan KS
Chron High Educ; 2006 Apr; 52(31):A29. PubMed ID: 16789295
[No Abstract] [Full Text] [Related]
12. Preparing individual patient data from clinical trials for sharing: the GlaxoSmithKline approach.
Hughes S; Wells K; McSorley P; Freeman A
Pharm Stat; 2014; 13(3):179-83. PubMed ID: 24668938
[TBL] [Abstract][Full Text] [Related]
13. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics.
Campbell MJ
Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038
[No Abstract] [Full Text] [Related]
14. Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment.
Baronikova S; Purvis J; Southam E; Beeso J; Panayi A; Winchester C
BMJ Evid Based Med; 2019 Oct; 24(5):177-184. PubMed ID: 30898790
[TBL] [Abstract][Full Text] [Related]
15. Authors' Submission Toolkit: a practical guide to getting your research published.
Chipperfield L; Citrome L; Clark J; David FS; Enck R; Evangelista M; Gonzalez J; Groves T; Magrann J; Mansi B; Miller C; Mooney LA; Murphy A; Shelton J; Walson PD; Weigel A
Curr Med Res Opin; 2010 Aug; 26(8):1967-82. PubMed ID: 20569069
[TBL] [Abstract][Full Text] [Related]
16. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
Newcombe JP; Kerridge IH
Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
[TBL] [Abstract][Full Text] [Related]
17. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
Mullins CD; Sanchez RJ
J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
[TBL] [Abstract][Full Text] [Related]
18. Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices.
Miller J; Ross JS; Wilenzick M; Mello MM
BMJ; 2019 Jul; 366():l4217. PubMed ID: 31292127
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial transparency and orphan drug development: recent trends in data sharing by the pharmaceutical industry.
So D; Joly Y; Knoppers BM
Public Health Genomics; 2013; 16(6):322-35. PubMed ID: 24503593
[TBL] [Abstract][Full Text] [Related]
20. European Federation of Statisticians in the Pharmaceutical Industry's position on access to clinical trial data.
Fletcher C; Driessen S; Burger HU; Gerlinger C; Biesheuvel E;
Pharm Stat; 2013; 12(6):333-6. PubMed ID: 24136872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
